SPAST and breast cancer: It is however recognised that a signal regulatory molecule can display a dichotomy of control, for example inhibiting proliferation in favour of increased invasion and survival in cancer cells [42], e.g. YB-1 in breast cancer [43] and spastin [44] in glioma, opposing properties confering a survival advantage during the development of micrometastasis [42].